loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for r0_cep_2020_147___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL (1)

filter

01 Benzylpenicillin (procaine) monohydrate (1)

filter

01 Netherlands (1)

filter

01 Valid (1)

Looking for Certificates of Suitability (CEPs) for R0-CEP 2020-147 - Rev 00 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl

Looking for Certificates of Suitability (CEPs) for R0-CEP 2020-147 - Rev 00 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl 1

20

Centrient Pharmaceuticals Netherlands B.v. Delft Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

One of their significant offerings is Benzylpenicillin (procaine) monohydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-147 - Rev 00

This Chemical Type CEP, issued on August 31, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 115 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY